Azafaros B.V., a clinical-stage biotechnology company focused on rare diseases and lysosomal storage disorders, today announced that advancements with its lead asset, nizubaglustat, will feature ...

A Nigerian student is glad that he has been presented with an award of N1.2 million after he made a poster presentation on a ...